logo
Select company
Select metric
-1533.08%Operating Cash Flow Margin
VS
Market
4
Sector
16
Industry
29
History
17
$ 2.37Close
$ 1.9 - $ 3.9 52-Week Range
Ticker Information

Ticker

LSTA

Company Name

LISATA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LISATA THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LSTA - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -16.4M-1533.08%$ 1.07M
3/31/2025$ -17.73M-1773.1%$ 1M
12/31/2024$ -19.36M-1935.6%$ 1M
9/30/2024$ -18.9M0%$ 0
6/30/2024$ -19.96M0%$ 0
3/31/2024$ -18.86M0%$ 0
12/31/2023$ -20.03M0%$ 0
9/30/2023$ -22.43M0%$ 0
6/30/2023$ -22.85M0%$ 0
3/31/2023$ -23.72M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LISATA THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 0%.
  • Over the past 5 years, LISATA THERAPEUTICS INC's average OCF % has been -1747.26%.
  • The median OCF % for LISATA THERAPEUTICS INC during this period was -1773.1%
  • LISATA THERAPEUTICS INC reached its highest OCF % over the past 5 years at -1533.08%.
  • The lowest OCF % recorded by LISATA THERAPEUTICS INC in the same timeframe -1935.6%

LISATA THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1031.07%RLYB : RALLYBIO CORP -5517.87%ICU : SEASTAR MEDICAL HOLDING CORP -2004.7%CLSD : CLEARSIDE BIOMEDICAL INC -1616.52%IGC : IGC PHARMA INC -335.34%RANI : RANI THERAPEUTICS HOLDINGS INC -2584.17%LEXX : LEXARIA BIOSCIENCE CORP -1574.8%APRE : APREA THERAPEUTICS INC -1514.98%PLUR : PLURI INC -1363.1%LYRA : LYRA THERAPEUTICS INC -5585.32%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for LISATA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -7.48M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]

LSTA - Operating Cash Flow Margin, Last 5 years

-1935.6%

Minimum

Dec 31, 2024

-1533.08%

Maximum

Jun 30, 2025

-1747.26%

Average

-1773.1%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%